Replies to post #362302 on Innovation Pharmaceuticals Inc (IPIX)

[MaskedCat]

If I recall sitting with a couple of presenters / attendees they went through the schedule beforehand to mark out which were of interest. These people are very serious people in their particular endeavors. Add to that , that GMU BDL is a big name and will have the attention it deserves.

Smiley face: SAVE THE BEST FOR LAST! Lol

[MaskedCat]

Note the last line:

2021 American Society of Virology Annual Meeting

JULYN 21, 2021

Antiviral data data related to Brilacidin, the Company’s defensin-mimetic drug candidate, has been accepted for an Oral Presentation at the American Society of Virology’s 40th Annual Meeting (ASV 2021), taking place July 19-23, 2021.

The presentation—“Brilacidin, a Host Defense Protein/Peptide Mimetic, Shows Potential as Broad Spectrum Inhibitor of Acutely Infectious Viruses”—is based on ongoing independent laboratory research being conducted by scientists at George Mason University (GMU)/National Center for Biodefense and Infectious Diseases (NCBID).

Brilacidin was shown to exhibit a potent inhibitory effect on SARS-CoV-2, the novel coronavirus responsible for COVID-19, as well as different types of alphaviruses, in cell culture.

——-Further details on the Brilacidin ASV 2021 presentation will be forthcoming.——-